NEWSMAKERS 

Julie Sutfcliffe

UC Davis scientist and surgeon team take on pancreatic cancer with SU2C grant
UC Davis scientist Julie Sutcliffe and surgical oncologist Richard Bold have been awarded a $1 million “New Therapies Challenge” grant from the Pancreatic Cancer Collective in an effort to improve survival for people with the disease.

The Collective is a strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C). The UC Davis team was one of seven to receive the grant, which could be augmented by an additional $4 million in the second round of funding.

Full Article

Dr. Chong-Xian Pan

Study seeks to improve cancer survival for Latinos, Asians and Blacks  
UC Davis leads University of California precision medicine effort to address vast cancer health disparities

UC Davis Comprehensive Cancer Center has received a $6.3 million grant from the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities for a 5-year study to tease out why some ethnic and racial minority groups fare worse than whites when they get cancer and to find more precise treatments to improve their chances of survival.

Full Article

Julie Sutcliffe

DAVIS, Calif. – Members of the World Molecular Imaging Society (WMIS) have chosen UC Davis’ Dr. Julie Sutcliffe, professor of internal medicine and biomedical engineering, as their 2020 president-elect.

Sutcliffe was nominated by peers and won the office following a members-only election that concluded September 1. She formally accepted her position as WMIS 2020 president-elect during the society’s annual meeting, which took place September 12 – 15 in Seattle. Her one-year term as WMIS president officially begins September 2019.

Click here for full article

Primo "Lucky" Lara, Jr.

Primo "Lucky" Lara named UC Davis Comprehensive Cancer Center Director

Please help us congradulate Dr. Primo Nery Lara, Jr. who has been named director of the National Cancer Institute-designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists with an estimated $90 million in annual research funding and a clinical enterprise that serves more than 10,000 adult and pediatric patients throughout the region every year.

“Dr. Lara is well-respected among his peers and his advice is sought by many,” said UC Davis School of Medicine Interim Dean Lars Berglund. “He is a resourceful and experienced leader, and I know he will build upon the strong foundation already in place at the Comprehensive Cancer Center to bring it to new heights and continued national prominence. With instrumental institutional support from both UC Davis Health and UC Davis, he is well-positioned to do so.”

Click here for Full Article

JOB OPPORTUNITITES

Seeking Full- Time Hospitalist

Seeking Faculty Positions